1
|
Steinwandel U, Davies H, Gibson N. Haemodiafiltration and haemodialysis should be reported separately by kidney replacement therapy registries. Clin Kidney J 2022; 15:1211-1212. [PMID: 35664284 PMCID: PMC9155220 DOI: 10.1093/ckj/sfac039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2022] [Indexed: 11/29/2022] Open
Affiliation(s)
- Ulrich Steinwandel
- School of Nursing and Midwifery, Edith Cowan University, Joondalup, Western Australia
| | - Hugh Davies
- School of Nursing and Midwifery, Edith Cowan University, Joondalup, Western Australia
| | - Nick Gibson
- School of Nursing and Midwifery, Edith Cowan University, Joondalup, Western Australia
| |
Collapse
|
2
|
Vernooij RWM, Bots ML, Strippoli GFM, Canaud B, Cromm K, Woodward M, Blankestijn PJ, Davenport A, Canaud B, Barth C, Strippoli G, Hegbrant J, Fischer K, Cromm K, Török M, Woodward M, Rose M, Bots M, Blankestijn P. CONVINCE in the context of existing evidence on haemodiafiltration. Nephrol Dial Transplant 2022; 37:1006-1013. [PMID: 35098994 PMCID: PMC9130023 DOI: 10.1093/ndt/gfac019] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2021] [Indexed: 11/14/2022] Open
Abstract
ABSTRACT
Haemodiafiltration (HDF) provides a greater removal of larger solutes and protein-bound compounds than conventional high-flux haemodialysis (HD). There are indications that the patients receiving the highest convection volumes of HDF result in an improved survival compared with HD. However, the comparative efficacy of HDF vs HD remains unproven. Here we provide a comparative account of the methodology and aims of ‘the comparison of high-dose HDF with high-flux HD’ (CONVINCE) study in the context of the totality of evidence and how this study will contribute to reaching a higher level of certainty regarding the comparative efficacy of HDF vs HD in people with end-stage kidney disease (ESKD).
Collapse
Affiliation(s)
- Robin W M Vernooij
- Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
| | - Michiel L Bots
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
| | - Giovanni F M Strippoli
- Department of Emergency and Organ Transplantation, University of Bari, Italy
- School of Public Health, University of Sydney, Australia
| | - Bernard Canaud
- Montpellier University, School of Medicine, Montpellier, France & Global Medical Office, FMC Deutschland, Bad Homburg, Germany
| | - Krister Cromm
- Fresenius Medical Care Deutschland GmbH, Global Medical Office, Bad Homburg v.d.H, Germany
| | - Mark Woodward
- The George Institute for Global Health, University of Oxford, Oxford, UK
- The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia
- Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA
| | - Peter J Blankestijn
- Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Ho CLB, Chih HJ, Garimella PS, Matsushita K, Jansen S, Reid CM. Prevalence and risk factors of peripheral artery disease in a population with chronic kidney disease in Australia: A systematic review and meta-analysis. Nephrology (Carlton) 2021; 26:798-808. [PMID: 34156137 DOI: 10.1111/nep.13914] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2021] [Revised: 05/27/2021] [Accepted: 06/08/2021] [Indexed: 12/24/2022]
Abstract
There is a lack of clarity and guidance for screening peripheral artery disease (PAD) in persons with chronic kidney disease (CKD) and end stage kidney disease (ESKD) despite this group being at excess risk of cardiovascular disease (CVD). In this current study, we performed a systematic review and meta-analysis to examine the prevalence and risk factors for PAD in persons with CKD in Australian cohorts. We used the inverse variance heterogeneity meta-analysis with double arcsine transformation to summarize the prevalence of PAD (with 95% CIs). Nine studies and 18 reports from the Australia and New Zealand dialysis and transplant registry with 36 cohorts were included in the review. We found a substantially higher PAD prevalence in cohorts based on an ankle-brachial index (ABI) or toe systolic pressure (TBI) than cohorts based on self-reported history. Higher PAD prevalence was observed in ESKD persons than CKD persons without dialysis (PAD diagnosis based on ABI or TBI: 31% in ESKD persons and 23% in CKD persons, PAD diagnosis based on self-reported history: 17% in ESKD persons and 10% in CKD persons). Older age, Caucasian race, cerebrovascular disease and haemodialysis were associated with the presence of PAD in ESKD persons. Our findings indicated a considerable proportion of PAD in CKD and ESKD persons particularly in those with ESKD. To develop and provide an adequate plan to clinically manage CKD patients with PAD, evidence of cost-effectiveness and clinical benefit of early detection of PAD in persons with CKD in Australia is recommended for future studies.
Collapse
Affiliation(s)
- Chau L B Ho
- School of Public Health, Curtin University, Perth, WA, Australia
| | - Hui J Chih
- School of Public Health, Curtin University, Perth, WA, Australia
| | - Pranav S Garimella
- Department of Medicine, University of California San Diego, California, USA
| | - Kunihiro Matsushita
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health and Division of Cardiology, Johns Hopkins School of Medicine, Maryland, USA.,Welch Center for Prevention, Epidemiology, and Clinical Research, Maryland, USA
| | - Shirley Jansen
- Curtin Medical School, Curtin University, Perth, WA, Australia.,Department of Vascular and Endovascular Surgery, Sir Charles Gairdner Hospital, Perth, WA, Australia.,Heart and Vascular Research Institute, Harry Perkins Institute for Medical Research, Perth, WA, Australia.,Faculty of Health and Medical Sciences, University of Western Australia, Perth, WA, Australia
| | - Christopher M Reid
- School of Public Health, Curtin University, Perth, WA, Australia.,CCRE Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| |
Collapse
|
4
|
Affiliation(s)
- Matthew J Damasiewicz
- Department of Nephrology, Monash Medical Centre, Monash Health, Clayton, Melbourne, Australia.,Department of Medicine and
| | - Kevan R Polkinghorne
- Department of Nephrology, Monash Medical Centre, Monash Health, Clayton, Melbourne, Australia.,Department of Medicine and.,Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| |
Collapse
|